Anti-Inflammatory And Immunomodulatory Potential Of Zetomipzomib (Kzr-616) For Active Systemic Lupus Erythematosus With Or Without Lupus Nephritis: Results From The Open-Label Mission Study (PANLAR 2023) - Apr 24, 2023 - Abstract #PANLAR2023-1457; Pres time: Apr 27, 2023; 12:00 PM - 01:20 PM; Location: Screen 5; No abstract available
Clinical • Immunomodulating • Glomerulonephritis • Immune Modulation • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus
|